Given the increasing advocacy for the use of inhaled corticosteroids a
s a treatment of choice for persistent asthma, growing numbers of chil
dren are being exposed to the possible growth-suppressing effects of g
lucocorticoids. Recent evidence strongly suggests that, when consisten
tly administered at moderate doses, inhaled corticosteroids (IC) are c
apable of slowing growth in children. Whether such growth suppression
would persist and ultimately affect final adult height remains unknown
. Therapeutic goals which aim for uninterrupted inflammatory disease c
ontrol rather than periodic symptom control may increase the occurrenc
e of growth failure in children treated with IC. In this article, curr
ent information about the mechanisms of growth suppression by glucocor
ticoids and the effects of IC on growth is reviewed, and recommendatio
ns for designing studies to investigate the effects of drugs on growth
are presented.